Targeting Strategies for Aberrant Lipid Metabolism Reprogramming and the Immune Microenvironment in Esophageal Cancer: A Review
Open Access
- 5 September 2022
- journal article
- review article
- Published by Wiley in Journal of Oncology
- Vol. 2022, 1-27
Abstract
Esophageal cancer is of high importance to occurrence, development, and treatment resistance. As evidenced by recent studies, pathways (e.g., Wnt/β-catenin, AMPK, and Hippo) are critical to the proliferation, differentiation, and self-renewal of esophageal cancer. In addition, the above pathways play a certain role in regulating esophageal cancer and act as potential therapeutic targets. Over the past few years, the function of lipid metabolism in controlling tumor cells and immune cells has aroused extensive attention. It has been reported that there are intricate interactions between lipid metabolism reprogramming between immune and esophageal cancer cells, whereas molecular mechanisms should be studied in depth. Immune cells have been commonly recognized as a vital player in the esophageal cancer microenvironment, having complex crosstalk with cancer cells. It is increasingly evidenced that the function of immune cells in the tumor microenvironment (TME) is significantly correlated with abnormal lipid metabolism. In this review, the latest findings in lipid metabolism reprogramming in TME are summarized, and the above findings are linked to esophageal cancer progression. Aberrant lipid metabolism and associated signaling pathways are likely to serve as a novel strategy to treat esophageal cancer through lipid metabolism reprogramming.Keywords
Funding Information
- National Natural Science Foundation of China (81770212, ZD201901)
- Changzhou City Health Commission major scientific and technological projects (81770212, ZD201901)
This publication has 203 references indexed in Scilit:
- Value of α‐methylacyl‐CoA racemase immunochemistry for predicting neoplastic progression in Barrett's oesophagusHistopathology, 2013
- Current Evidence Linking Polyunsaturated Fatty Acids with Cancer Risk and ProgressionFrontiers in Oncology, 2013
- Suppressing the formation of lipid raft‐associated Rac1/PI3K/Akt signaling complexes by curcumin inhibits SDF‐1α‐induced invasion of human esophageal carcinoma cellsMolecular Carcinogenesis, 2012
- Curcumin Induces Cell Death in Esophageal Cancer Cells through Modulating Notch SignalingPLOS ONE, 2012
- Bile Acid and Inflammation Activate Gastric Cardia Stem Cells in a Mouse Model of Barrett-Like MetaplasiaCancer Cell, 2012
- HIF1α–dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cellsJournal of Experimental Medicine, 2011
- The Accumulation and Prognosis Value of Tumor Infiltrating IL-17 Producing Cells in Esophageal Squamous Cell CarcinomaPLOS ONE, 2011
- Barrett's esophagus, esophageal and esophagogastric junction adenocarcinomas: The role of dietClinics and Research in Hepatology and Gastroenterology, 2011
- Pro-Inflammatory CD11c+CD206+ Adipose Tissue Macrophages Are Associated With Insulin Resistance in Human ObesityDiabetes, 2010
- CD4+ T‐cell activation is differentially modulated by bacteria‐primed dendritic cells, but is generally down‐regulated by n‐3 polyunsaturated fatty acidsImmunology, 2010